Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023)
Labcorp Holdings' (LH) quarterly Cash from Discontinued Operations came in at $189.9 million in Q2 2023, up 394.42% quarter-over-quarter from -$64.5 million in Q1 2023.
Powered by 
Analysis
Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Labcorp Holdings has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting $189.9 million for Q2 2023.
- In Q2 2023, Cash from Discontinued Operations changed N/A year-over-year to $189.9 million; the TTM figure through Mar 2024 stood at $189.9 million (changed N/A YoY), while the FY2023 annual figure was $125.4 million, down 34.38% from the prior year.
- Cash from Discontinued Operations came in at $189.9 million for Q2 2023 at Labcorp Holdings, up from -$64.5 million in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of $189.9 million in Q2 2023 to a low of -$64.5 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | - |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 189.90 Mn |
| Mar 31, 2023 | -64.50 Mn |
| Dec 31, 2022 | 46.40 Mn |
| Sep 30, 2022 | 120.80 Mn |